Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels.
作者信息
Ward H W
出版信息
Br Med J. 1973 Jan 6;1(5844):13-4. doi: 10.1136/bmj.1.5844.13.
Abstract
摘要
相似文献
1
Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels.乳腺癌的抗雌激素治疗：两种剂量水平他莫昔芬的试验
Br Med J. 1973 Jan 6;1(5844):13-4. doi: 10.1136/bmj.1.5844.13.
2
Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.他莫昔芬在晚期乳腺癌中的治疗应用：与生化参数的相关性
Cancer Treat Rep. 1976 Oct;60(10):1437-43.
3
A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474.一种用于晚期乳腺癌的新型抗雌激素药物。ICI46474的早期临床评估。
Br J Cancer. 1971 Jun;25(2):270-5. doi: 10.1038/bjc.1971.33.
4
Antiestrogen-induced remissions in stage IV breast cancer.抗雌激素诱导的IV期乳腺癌缓解
Cancer Treat Rep. 1976 Oct;60(10):1445-50.
5
[Clinical evaluation of the antioestrogenic agent tamoxifen in the treatment of metastatic breast cancer (author's transl)].
Wien Klin Wochenschr. 1978 Feb 17;90(4):133-41.
6
Anti-oestrogen therapy of advanced mammary carcinoma.
Acta Radiol Ther Phys Biol. 1976 Dec;15(6):513-8. doi: 10.3109/02841867609131975.
7
Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.他莫昔芬与氨鲁米特治疗晚期乳腺癌的随机交叉试验
Br Med J (Clin Res Ed). 1981 Nov 28;283(6304):1432-4. doi: 10.1136/bmj.283.6304.1432.
8
Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs.他莫昔芬和其他抗雌激素药物的毒性和不良反应。
Pharmacol Ther. 2013 Sep;139(3):392-404. doi: 10.1016/j.pharmthera.2013.05.005. Epub 2013 May 24.
9
10
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.他莫昔芬用于早期乳腺癌：随机试验综述。早期乳腺癌试验者协作组
Lancet. 1998 May 16;351(9114):1451-67.
引用本文的文献
1
Behavior of Osteoblastic Lineage Cells When in the Presence of Tamoxifen: In Vitro and In Vivo Studies on Osseointegration.成骨细胞系细胞在他莫昔芬存在时的行为：骨整合的体外和体内研究
Dent J (Basel). 2025 Aug 1;13(8):351. doi: 10.3390/dj13080351.
2
Exploring the molecular mechanisms of comorbidity between thyroid cancer and breast cancer through multi-omics data.通过多组学数据探索甲状腺癌和乳腺癌共病的分子机制。
Sci Rep. 2025 Jul 2;15(1):23309. doi: 10.1038/s41598-025-06566-w.
3
How to choose optimal adjuvant therapies for high-risk hormone receptor-positive, HER2-negative breast cancer after chemotherapy?化疗后，如何为高危激素受体阳性、人表皮生长因子受体2阴性乳腺癌选择最佳辅助治疗方法？
Acta Oncol. 2025 Jun 25;64:815-829. doi: 10.2340/1651-226X.2025.43645.
4
Bibliometric Analysis of The Global Research Trends on The Application of Tamoxifen in The Treatment of Breast Cancer Over The Past 50 Years.过去50年他莫昔芬在乳腺癌治疗中应用的全球研究趋势的文献计量分析
Malays J Med Sci. 2025 Feb;32(1):35-55. doi: 10.21315/mjms-06-2024-452. Epub 2025 Feb 28.
5
Pharmacogenetics of tamoxifen in breast cancer patients of African descent: Lack of data.非洲裔乳腺癌患者他莫昔芬的药物遗传学：缺乏数据。
Clin Transl Sci. 2024 Mar;17(3):e13761. doi: 10.1111/cts.13761.
6
Tamoxifen evolution.他莫昔芬的演变
Br J Cancer. 2023 Feb;128(3):421-425. doi: 10.1038/s41416-023-02158-5. Epub 2023 Feb 10.
7
Adrenal Steroids and Resistance to Hormonal Blockade of Prostate and Breast Cancer.肾上腺皮质类固醇与前列腺癌和乳腺癌对激素阻断的抵抗。
Endocrinology. 2023 Jan 9;164(3). doi: 10.1210/endocr/bqac218.
8
Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier.乳腺癌的抗激素治疗及其对血脑屏障的影响。
Cancers (Basel). 2022 Oct 19;14(20):5132. doi: 10.3390/cancers14205132.
9
The History of Early Breast Cancer Treatment.早期乳腺癌治疗的历史。
Genes (Basel). 2022 May 27;13(6):960. doi: 10.3390/genes13060960.
10
Evolution of Medical Approaches and Prominent Therapies in Breast Cancer.乳腺癌医学治疗方法及主要疗法的演变
Cancers (Basel). 2022 May 16;14(10):2450. doi: 10.3390/cancers14102450.
本文引用的文献
1
Observations on the use of a non-steroidal estrogen antagonist: MER-25.
Surg Forum. 1960;10:725-9.
2
CLOMIPHENE CITRATE (NSC-35770) IN DISSEMINATED MAMMARY CARCINOMA.枸橼酸氯米芬（NSC - 35770）治疗播散性乳腺癌
Cancer Chemother Rep. 1964 Dec;43:39-41.
3
A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474.一种用于晚期乳腺癌的新型抗雌激素药物。ICI46474的早期临床评估。
Br J Cancer. 1971 Jun;25(2):270-5. doi: 10.1038/bjc.1971.33.
Zotero 插件